• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.

作者信息

Nii Masaki, Inuzuka Ryo, Inai Kei, Shimada Eriko, Shinohara Tokuko, Kogiso Tomomi, Ono Hiroshi, Ootsuki Shinichi, Kurita Yoshihiko, Takeda Atsuhito, Hirono Keiichi, Takei Kota, Yasukochi Satoshi, Yoshikawa Tadahiro, Furutani Yoshiyuki, Shinozaki Tomohiro, Matsuyama Yutaka, Senzaki Hideaki, Tokushige Katsutoshi, Nakanishi Toshio

机构信息

Department of Pediatric Cardiology, Shizuoka Children's Hospital, Japan (M.N.).

Departments of Pediatrics (R.I.), University of Tokyo, Japan.

出版信息

Circulation. 2021 Dec 21;144(25):2043-2045. doi: 10.1161/CIRCULATIONAHA.121.056870. Epub 2021 Dec 20.

DOI:10.1161/CIRCULATIONAHA.121.056870
PMID:34928702
Abstract
摘要

相似文献

1
Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.Fontan手术后肝硬化和肝细胞癌的发病率及预期概率
Circulation. 2021 Dec 21;144(25):2043-2045. doi: 10.1161/CIRCULATIONAHA.121.056870. Epub 2021 Dec 20.
2
Liver Cirrhosis and Hepatocellular Carcinoma After the Fontan Operation: Reaching Clarity in the Face of Uncertainty.Fontan手术后的肝硬化和肝细胞癌：在不确定性中寻求明晰
Circulation. 2021 Dec 21;144(25):1977-1980. doi: 10.1161/CIRCULATIONAHA.121.057431. Epub 2021 Dec 20.
3
A liver mass post-Fontan operation.Fontan手术后的肝脏肿块。
QJM. 2014 Jul;107(7):571-2. doi: 10.1093/qjmed/hcu020. Epub 2014 Mar 11.
4
Surveillance for liver complications after the Fontan procedure.Fontan手术后肝脏并发症的监测。
Congenit Heart Dis. 2017 Mar;12(2):124-132. doi: 10.1111/chd.12446. Epub 2017 Jan 31.
5
Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure　- A Nationwide Survey in Japan.《Fontan 手术后晚期发生的肝硬化和/或肝细胞癌：日本全国性调查》
Circ J. 2018 Mar 23;82(4):1155-1160. doi: 10.1253/circj.CJ-17-1053. Epub 2018 Feb 14.
6
Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.磁共振弹性成像：一种用于检测Fontan手术后肝纤维化和肝细胞癌的新技术。
Mayo Clin Proc. 2015 Jul;90(7):882-94. doi: 10.1016/j.mayocp.2015.04.020. Epub 2015 Jun 6.
7
Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.接受Fontan手术患者的肝脏病理进展：慢性被动性充血、心源性肝硬化、肝腺瘤和肝细胞癌。
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1348-52. doi: 10.1016/j.jtcvs.2004.10.005.
8
Fontan-associated liver disease: A review.Fontan 相关肝疾病：综述。
J Cardiol. 2019 Sep;74(3):223-232. doi: 10.1016/j.jjcc.2019.02.016. Epub 2019 Mar 28.
9
Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening.三例Fontan手术患者的肝细胞癌：文献综述及肝脏筛查建议
Int J Cardiol. 2016 Mar 1;206:21-6. doi: 10.1016/j.ijcard.2015.12.033. Epub 2016 Jan 2.
10
HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE.Fontan手术后出现心脏肝硬化的肝细胞癌
Gastroenterol Nurs. 2018 Jan/Feb;41(1):68-71. doi: 10.1097/SGA.0000000000000350.

引用本文的文献

1
Strain elastography for detecting advanced Fontan-associated liver disease: a retrospective study.应变弹性成像技术用于检测晚期Fontan相关肝病：一项回顾性研究。
BMC Gastroenterol. 2025 May 8;25(1):341. doi: 10.1186/s12876-025-03965-1.
2
Prevalence, Risk Factors, and Prognosis for Fontan-Associated Liver Disease: A Systematic Review and Exploratory Meta-Analysis.Fontan相关肝病的患病率、危险因素及预后：一项系统评价与探索性Meta分析
JACC Adv. 2025 Mar 25;4(5):101694. doi: 10.1016/j.jacadv.2025.101694.
3
Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation.
Fontan手术后肝细胞癌的特征与生存结局
JACC Adv. 2025 Apr;4(4):101646. doi: 10.1016/j.jacadv.2025.101646. Epub 2025 Mar 12.
4
Long-term outcomes of extracardiac Gore-Tex conduits in Fontan patients.Fontan手术患者心外Gore-Tex导管的长期预后
Int J Cardiol Congenit Heart Dis. 2024 Mar 8;16:100505. doi: 10.1016/j.ijcchd.2024.100505. eCollection 2024 Jun.
5
From Fragmented Data to Actionable Insights: Predicting HCC in Fontan Patients-A Call for Collaboration.从碎片化数据到可操作的见解：预测Fontan患者的肝癌——呼吁合作
Dig Dis Sci. 2024 Dec;69(12):4333-4335. doi: 10.1007/s10620-024-08678-1. Epub 2024 Oct 28.
6
Effects of Bushen Huayu Decoction combined with entecavir on liver function and hepatic fibrosis in patients with compensated cirrhosis.补肾化瘀汤联合恩替卡韦对代偿期肝硬化患者肝功能及肝纤维化的影响
Am J Transl Res. 2024 Aug 15;16(8):4163-4173. doi: 10.62347/QDXJ3369. eCollection 2024.
7
A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.Fontan 术后肝细胞癌累积发生率的荟萃分析。
Dig Dis Sci. 2024 Dec;69(12):4467-4475. doi: 10.1007/s10620-024-08470-1. Epub 2024 Jun 13.
8
Severe Fontan-Associated Liver Disease and Its Association With Mortality.严重的 Fontan 相关肝疾病及其与死亡率的关系。
J Am Heart Assoc. 2023 Oct 3;12(19):e024034. doi: 10.1161/JAHA.121.024034. Epub 2023 Sep 30.
9
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.肝硬化及其相关并发症的流行病学：当前知识和未来方向。
World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910.
10
Risk factors for Fontan-associated hepatocellular carcinoma.Fontan 相关肝细胞癌的风险因素。
PLoS One. 2022 Jun 17;17(6):e0270230. doi: 10.1371/journal.pone.0270230. eCollection 2022.